Allergic rhinitis or hay fever is an IgE-mediated disorder caused by allergens such as mold or tress, animal, dander, house dust mites, weed pollens, and grass. It can occur in two different forms namely, seasonal and perennial, which in turn causes mild or moderate to severe inflammation inside the nose. Some of the major symptoms of allergic rhinitis include nasal congestion, rhinorrhea, sneezing, nasal itching, and itchy eyes, or it can be associated with asthma as well. Allergic rhinitis and sinusitis are linked to each other, as allergic rhinitis blocks the nose, which in turn blocks the sinuses. In 2015, according to World Allergy Organization, over 400 million people suffered from allergic rhinitis worldwide. Moreover, in the U.S., 10-30% adults and around 40% children were affected by allergic rhinitis.
Global Allergic Rhinitis Drugs Market Taxonomy:
By Drug Class:
By Distribution Channel:
Introduction of new drugs is expected to drive growth of the market
Manufacturers are developing a variety of drugs and nasal sprays for the treatment of allergic rhinitis. This in turn, is expected to fuel growth of the allergic rhinitis drugs market in the near future. For instance, in March 2017, the U.S. Food and Drug Administration (FDA) approved Odactra drug, manufactured by Catalent Pharma Solutions Limited, the first allergen extract to be administered under the tongue (sublingually), to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis), for people aged between18 and 65 years. In 2016, Aralez Pharmaceutical Inc. launched Blexten, for the treatment of symptoms related to seasonal allergic rhinitis (SAR) and chronic spontaneous urticarial (CSU) in Canada. Moreover, in January 2017, Pediapharm Inc. launched an innovative allergy medication – Rupall, in a tablet and oral form, which is a first prescription antihistamine with three indications namely, symptoms associated with seasonal allergic rhinitis (SAR), perennial allergic rhinitis (PAR), and chronic spontaneous urticaria (CSU), for people aged 2 years and above suffering from the allergy. Moreover, growing drug pipeline for the treatment of allergy rhinitis is expected to contribute substantially to the market growth. For instance, GenMont Biotech is developing eN-Lac for the treatment of allergy rhinitis. The drug is in phase III and is expected to be introduced in the market during the forecast period.
Higher prevalence and incidence of allergy rhinitis among people is expected to fuel growth of the allergic rhinitis drugs market
Increasing prevalence of allergy rhinitis is a major factor propelling growth of the allergic rhinitis drugs market in the near future. For instance, in 2012, according to American Academy of Allergy, Asthma, and Immunology, around 17.6 million adults and 6.6 million children were diagnosed with hay fever in the U.S. Moreover, according to International Study on Asthma and Allergies in Childhood (ISAAC), in 2015, prevalence of allergic rhinitis symptoms varied between 0.8 % and 14.9 % in children, aged 6 to 7 years and 1.4 % and 39.7 % in 13 to 14 years old worldwide.
According to European Academy of Allergy and Clinical Immunology (EAACI), in 2016, over 150 million of people suffered from chronic allergic diseases in Europe and it is predicated that around half of the entire population will be affected by 2025.
Key player operating in the allergic rhinitis drugs market include GlaxoSmithKline plc, Adamis Pharmaceuticals, ALK-Abello, Dr Reddy's Laboratories, Allergy Therapeutics, Lupin Pharmaceuticals, Array BioPharma, Hanmi Pharmaceuticals, Mylan NV, and Sun Pharmaceuticals.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]arketinsights.com
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.